health status indicators

健康状况指标
  • 文章类型: Journal Article
    在中国慢性病和危险因素监测中,使用了核心健康日措施来跟踪人群水平的健康状况;但是,它们不容易组合在一起,以创建总体健康相关生活质量(HRQOL)的摘要,限制此指示器的使用。
    本研究旨在根据中文版本的核心健康日指标(HRQOL-5)制定汇总评分,并将其用于估计中国人群的HRQOL及其决定因素。
    2018年11月至2019年5月,对潍坊市15岁以上常住人口进行了多阶段分层整群调查,调查人群健康状况和行为危险因素,山东省,中国。进行了探索性因素分析和验证性因素分析,以揭示HRQOL-5的潜在结构,然后通过计算其汇总分数来量化整体HRQOL。最后进行Tobit回归模型,找出汇总得分的影响因素。
    本研究共纳入26,269名参与者(男性:n=13,571,51.7%;平均年龄55.9,SD14.9岁)。共有71%(n=18,663)的受访者表示他们的总体健康状况良好或非常好。使用探索性因子分析提取一个汇总因子以捕获总体HRQOL。验证性因子分析进一步证实了这种单因素模型(塔克-刘易斯指数,比较拟合指数,且拟合优度指数>0.90;均方根误差近似为0.02)。多因素Tobit回归分析显示,年龄(β=-0.06),教育造诣(小学:β=0.72;初中:β=1.46;高中以上:β=2.58),平均收入(≥30,000日元[4200美元]:β=0.69),身体活动(β=0.75),饮酒(β=0.46),自我报告疾病(β=-6.36),自我报告损伤(β=-5.00)是影响HRQOL-5总分的主要因素。
    这项研究从HRQOL-5中构建了一个汇总评分,提供了人口水平HRQOL的综合表示。不同亚群汇总得分的差异可能有助于确定中国卫生规划的优先事项,以改善人口HRQOL。
    UNASSIGNED: The core Healthy Days measures were used to track the population-level health status in the China Chronic Disease and Risk Factor Surveillance; however, they were not easily combined to create a summary of the overall health-related quality of life (HRQOL), limiting this indicator\'s use.
    UNASSIGNED: This study aims to develop a summary score based on the Chinese version of the core Healthy Days measures (HRQOL-5) and apply it to estimate HRQOL and its determinants in a Chinese population.
    UNASSIGNED: From November 2018 to May 2019, a multistage stratified cluster survey was conducted to examine population health status and behavioral risk factors among the resident population older than 15 years in Weifang City, Shandong Province, China. Both exploratory factor analyses and confirmatory factor analyses were performed to reveal the underlying latent construct of HRQOL-5 and then to quantify the overall HRQOL by calculating its summary score. Tobit regression models were finally carried out to identify the influencing factors of the summary score.
    UNASSIGNED: A total of 26,269 participants (male: n=13,571, 51.7%; mean age 55.9, SD 14.9 years) were included in this study. A total of 71% (n=18,663) of respondents reported that they had excellent or very good general health. One summary factor was extracted to capture overall HRQOL using exploratory factor analysis. The confirmatory factor analysis further confirmed this one-factor model (Tucker-Lewis index, comparative fit index, and goodness-of-fit index >0.90; root mean square error of approximation 0.02). Multivariate Tobit regression analysis showed that age (β=-0.06), educational attainments (primary school: β=0.72; junior middle school: β=1.46; senior middle school or more: β=2.58), average income (≥¥30,000 [US $4200]: β=0.69), physical activity (β=0.75), alcohol use (β=0.46), self-reported disease (β=-6.36), and self-reported injury (β=-5.00) were the major influencing factors on the summary score of the HRQOL-5.
    UNASSIGNED: This study constructs a summary score from the HRQOL-5, providing a comprehensive representation of population-level HRQOL. Differences in summary scores of different subpopulations may help set priorities for health planning in China to improve population HRQOL.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:据报道,在美国成年人中,基于较高的生命必需8(LE8)的心血管健康(CVH)与全因死亡率和心脑血管疾病(CCVD)相关死亡率的较低风险相关。同时,多项研究表明,CVH与卒中和CCVD风险显著负相关.由于没有研究调查LE8在中风患者中的适用性,本研究旨在探讨LE8与卒中患者全因死亡率和心脑血管死亡率的关系.
    方法:在这项回顾性队列研究中,从2007-2018年的国家健康与营养调查(NHANES)数据库中提取患者数据。使用加权单变量和多变量COX回归分析来研究LE8与全因死亡率和心脑血管死亡率的关联。我们进一步探索了年龄亚组中的这些关系,性别,体重指数(BMI),癌症,充血性心力衰竭(CHF),冠心病(CHD)。评价指标为风险比(HRs)和95%置信区间(CIs)。
    结果:在符合条件的患者中,278人死于全因,其中89人(8.38%)死于CCVD。在调整协变量后,LE8评分≥58.75的患者全因死亡率(HR=0.46,95CI:0.31-0.69)和心脑血管死亡率(HR=0.51,95CI:0.26-0.98)的风险较低,与LE8评分<48.123的人相比。在年龄<65岁的患者中,较高的LE8评分与较低的全因死亡风险相关。没有癌症,不管性别是什么,BMI,CHF或CHD条件(均P<0.05)。仅在年龄<65岁和非癌症亚组中发现高LE8评分与低心脑血管死亡风险之间存在相关性(均P<0.05)。
    结论:较高的LE8评分与卒中患者全因死亡率和心脑血管死亡率的风险较低相关,为脑卒中的风险管理和预后改善提供一定的参考。然而,需要更多的证据来验证高LE8评分在卒中预后中的有益作用.
    BACKGROUND: A higher Life\'s Essential 8 (LE8)-based cardiovascular health (CVH) has been reported to be associated with a lower risk of both all-cause mortality and cardio-cerebrovascular diseases (CCVDs) related mortality in adults in the United States. At the same time, multiple studies have shown a significant negative association of CVH with the risk of stroke and CCVDs. Since no research has investigated the applicability of the LE8 in stroke patients, this study aimed to explore the association of LE8 with all-cause mortality and cardio-cerebrovascular mortality in stroke patients.
    METHODS: Data of patients were extracted from the National Health and Nutrition Examination Surveys (NHANES) database in 2007-2018 in this retrospective cohort study. Weighted univariate and multivariate COX regression analyses were utilized to investigate the associations of LE8 with all-cause mortality and cardio-cerebrovascular mortality. We further explored these relationships in subgroups of age, gender, body mass index (BMI), cancer, congestive heart failure (CHF), and coronary heart disease (CHD). The evaluation indexes were hazard ratios (HRs) and 95% confidence intervals (CIs).
    RESULTS: Among the eligible patients, 278 died from all-cause and 89 (8.38%) of them died due to CCVDs. After adjusting for covariates, patients with LE8 score ≥ 58.75 seemed to have both lower risk of all-cause mortality (HR = 0.46, 95%CI: 0.31-0.69) and cardio-cerebrovascular mortality (HR = 0.51, 95%CI: 0.26-0.98), comparing to those with LE8 score < 48.123. Higher LE8 scores were associated with lower risk of all-cause mortality in patients aged < 65 years old, without cancer, and whatever the gender, BMI, CHF or CHD conditions (all P < 0.05). The relationships between high LE8 scores and low cardio-cerebrovascular mortality risk were only found in age < 65 years old and non-cancer subgroups (all P < 0.05).
    CONCLUSIONS: A higher LE8 score was associated with lower risk of both all-cause mortality and cardio-cerebrovascular mortality in patients with stroke, which may provide some reference for risk management and prognosis improvement in stoke. However, more evidences are needed to verify this beneficial role of high LE8 score in stroke prognosis.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    体格检查数据用于表明个人健康状况和器官健康状况,了解哪些体检数据表明生理衰老对于健康管理和早期干预至关重要。缺少对体检数据和端粒长度的研讨。因此,本研究分析了不同年龄健康人的血液端粒长度与体检指标之间的关系,以探讨人体各种器官/系统与生理衰老的作用和关系。本研究为横断面研究。选择了16种不同组织和器官健康状况的体检指标,并分析了与实际年龄和端粒长度(TL)相关的趋势。该研究包括632名个体,共有11,766名16项体检指标的数据。年龄与11个指标呈线性相关。有趣的是,端粒长度仅与肾脏指标eGFR密切相关(P<.001),CYS-C(P<.001),和SCR(P<.001)。该研究确定肾脏老化或损伤是人体身体老化的危险因素。早期识别和管理对医疗保健至关重要。
    Physical examination data are used to indicate individual health status and organ health, and understanding which physical examination data are indicative of physiological aging is critical for health management and early intervention. There is a lack of research on physical examination data and telomere length. Therefore, the present study analyzed the association between blood telomere length and physical examination indices in healthy people of different ages to investigate the role and association of various organs/systems with physiological aging in the human body. The present study was a cross-sectional study. Sixteen physical examination indicators of different tissue and organ health status were selected and analyzed for trends in relation to actual age and telomere length (TL). The study included 632 individuals with a total of 11,766 data for 16 physical examination indicators. Age was linearly correlated with 11 indicators. Interestingly, telomere length was strongly correlated only with the renal indicators eGFR (P < .001), CYS-C (P < .001), and SCR (P < .001). The study established that renal aging or injury is a risk factor for Physical aging of the human body. Early identification and management are essential to healthcare.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:改善青少年健康测量,全球青少年健康测量行动(GAMA)咨询小组于2018年成立,并于2022年发布了6个青少年健康领域的52项指标清单草案.我们描述了选择GAMA推荐的青少年健康指标的过程和结果(以下,\"GAMA推荐指标\")。
    方法:使用以下输入对清单草案中的每个指标进行了评估:(1)数据的可用性和利益相关者对其相关性的看法,可接受性,和可行性;(2)与当前的衡量建议和做法保持一致;(3)全球数据库中的数据。由GAMA专家和联合国伙伴机构代表组成的特定主题工作组审查了结果并提出了初步建议,由所有GAMA成员评估并最终确定。
    结果:有47个GAMA推荐的指标(36个核心指标和11个额外指标)用于六个领域的青少年健康测量:政策,programs,和法律(4个指标);系统性能和干预措施(4);健康决定因素(7);健康行为和风险(20);主观幸福感(2);以及健康结果和条件(10)。
    结论:这些指标是一个稳健和结构化的五年过程的结果,以确定与全球青少年健康相关的一组优先指标。这种包容性和参与性方法纳入了广泛利益攸关方的投入,包括青少年和年轻人本身。GAMA推荐的指标现已准备用于衡量该国的青少年健康状况,区域,和全球层面。
    OBJECTIVE: To improve adolescent health measurement, the Global Action for the Measurement of Adolescent health (GAMA) Advisory Group was formed in 2018 and published a draft list of 52 indicators across six adolescent health domains in 2022. We describe the process and results of selecting the adolescent health indicators recommended by GAMA (hereafter, \"GAMA-recommended indicators\").
    METHODS: Each indicator in the draft list was assessed using the following inputs: (1) availability of data and stakeholders\' perceptions on their relevance, acceptability, and feasibility across selected countries; (2) alignment with current measurement recommendations and practices; and (3) data in global databases. Topic-specific working groups comprised of GAMA experts and representatives of United Nations partner agencies reviewed results and provided preliminary recommendations, which were appraised by all GAMA members and finalized.
    RESULTS: There are 47 GAMA-recommended indicators (36 core and 11 additional) for adolescent health measurement across six domains: policies, programs, and laws (4 indicators); systems performance and interventions (4); health determinants (7); health behaviors and risks (20); subjective well-being (2); and health outcomes and conditions (10).
    CONCLUSIONS: These indicators are the result of a robust and structured five-year process to identify a priority set of indicators with relevance to adolescent health globally. This inclusive and participatory approach incorporated inputs from a broad range of stakeholders, including adolescents and young people themselves. The GAMA-recommended indicators are now ready to be used to measure adolescent health at the country, regional, and global levels.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的:我们的研究调查了美国冠心病(CHD)患者心血管健康指标的变化趋势及其与全因死亡率和心血管疾病死亡率的关系。
    结果:该队列研究是根据1999-2018年国家健康和营养检查调查及其相关死亡率文件(至2019年)进行的。基线冠心病被定义为自我报告的医生诊断的冠心病的复合,心肌梗塞,还有心绞痛.根据美国心脏协会的建议评估心血管健康指标。长期全因死亡率和心血管疾病死亡率是主要结果。使用调查调整的Cox回归模型来估计心血管健康指标与全因死亡率和心血管疾病死亡率之间关联的风险比和相应的95%置信区间。一个或更少的理想心血管健康指标的患病率在冠心病中从14.15%增加到22.79%(P<0.001)。从1999年到2018年,超过4个理想心血管健康指标的患病率分别从21.65%降至15.70%(P<0.001)。与具有一个或更少的理想心血管健康指标的冠心病参与者相比,那些具有四个或更多理想心血管健康指标的人的风险降低了35%(风险比,0.65;95%置信区间:0.51,0.82)和全因和心血管疾病死亡率的风险降低44%(0.56;0.38,0.84),分别。
    结论:在美国成人冠心病患者中,理想的心血管健康指标显著下降。较高数量的心血管健康指标与较低的全因死亡率和心血管疾病死亡率相关。
    OBJECTIVE: Our study examined the trends of cardiovascular health metrics in individuals with coronary heart disease (CHD) and their associations with all-cause and cardiovascular disease mortality in the US.
    RESULTS: The cohort study was conducted based on the National Health and Nutrition Examination Survey 1999-2018 and their linked mortality files (through 2019). Baseline CHD was defined as a composite of self-reported doctor-diagnosed coronary heart disease, myocardial infarction, and angina pectoris. Cardiovascular health metrics were assessed according to the American Heart Association recommendations. Long-term all-cause and cardiovascular disease mortality were the primary outcomes. Survey-adjusted Cox regression models were used to estimate hazard ratios and corresponding 95% confidence intervals for the associations between cardiovascular health metrics and all-cause and cardiovascular disease mortality. The prevalence of one or fewer ideal cardiovascular health metrics increased from 14.15% to 22.79% (P < 0.001) in CHD, while the prevalence of more than four ideal cardiovascular health metrics decreased from 21.65% to 15.70 % (P < 0.001) from 1999 to 2018, respectively. Compared with CHD participants with one or fewer ideal cardiovascular health metrics, those with four or more ideal cardiovascular health metrics had a 35% lower risk (hazard ratio, 0.65; 95% confidence interval: 0.51, 0.82) and a 44% lower risk (0.56; 0.38, 0.84) in all-cause and cardiovascular disease mortality, respectively.
    CONCLUSIONS: Substantial declines were noted in ideal cardiovascular health metrics in US adults with CHD. A higher number of cardiovascular health metrics was associated with lower all-cause and cardiovascular disease mortality in them.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Systematic Review
    背景:满足24小时运动指南(即,身体活动,久坐的行为,睡眠)可以为残疾人带来健康益处。然而,没有系统评价或荟萃分析对符合这些指南的患病率以及与健康指标的相关性进行过研究.
    目的:本系统综述和荟萃分析旨在研究残疾人中符合24小时运动指南的患病率以及与健康指标的关联。
    方法:从开始到2023年5月31日,搜索了六个电子数据库以英文发表的研究。使用随机效应模型的荟萃分析来确定满足24小时运动指南的患病率。采用定性综合来描述满足指南与健康指标之间的关联。
    结果:确定了24项研究,包括来自8个国家的77510名年龄在6-65岁的残疾参与者(41.6%为女性)。总的来说,6.97%的残疾参与者符合所有24小时运动指南,16.65%不符合任何准则。在满足所有指南时,发现年龄(P=0.006)和残疾类型(P=0.001)存在显着差异。符合所有指南的残疾参与者报告的心理社会健康指标(9/9研究)比没有或只有一个指南的参与者更好。其他健康指标的证据或研究有限。
    结论:有一些证据表明,残疾人士符合所有24小时运动指南的患病率较低。同时,有初步证据表明,与不符合任何指南相比,符合所有指南与更好的社会心理健康状况相关.
    BACKGROUND: Meeting the 24-h movement guidelines (i.e., physical activity, sedentary behavior, sleep) could generate health benefits to people with disabilities. However, no systematic reviews or meta-analyses have examined the prevalence of meeting these guidelines and associations with health indicators in this group.
    OBJECTIVE: This systematic review and meta-analysis aimed to examine the prevalence of meeting the 24-h movement guidelines and associations with health indicators among people with disabilities.
    METHODS: Six electronic databases were searched for studies published in English from inception to May 31, 2023. Meta-analyses with the random-effects model were used to determine the prevalence of meeting the 24-h movement guidelines. Qualitative syntheses were employed to describe the associations between meeting the guidelines and health indicators.
    RESULTS: Twenty-four studies comprising 77510 participants (41.6% females) with disabilities aged 6-65 years from eight countries were identified. Overall, 6.97% of the participants with disabilities met all 24-h movement guidelines, and 16.65% met none of the guidelines. Significant age (P = 0.006) and disability type (P = 0.001) differences were found in meeting all guidelines. Participants with disabilities who met all guidelines reported better psychosocial health indicators (9/9 studies) than those met none or only one of the guidelines. There was limited evidence or research for other health indicators.
    CONCLUSIONS: There is some evidence showing that the prevalence of meeting all 24-h movement guidelines in people with disabilities is low. Meanwhile, there is preliminary evidence suggesting that meeting all guidelines is associated with better psychosocial health than meeting none of the guidelines.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    在非肥胖个体中越来越多地观察到非酒精性脂肪性肝病(NAFLD)。ZJU(浙江大学)指数已被建立为检测NAFLD的新型高效工具,但在非肥胖个体中,ZJU指数与NAFLD之间的关系仍不清楚.
    使用温州医学中心的健康评估数据库中的数据进行了事后评估。根据ZJU指数的四分位数将参与者分为四组。Cox比例风险回归,使用Kaplan-Meier分析和线性趋势检验来评估ZJU指数与NAFLD发病率之间的关系。采用亚组分析检验亚组中ZJU与NAFLD相关性的一致性。进行受试者工作特征(ROC)曲线分析以评估ZJU指数的预测性能,与血浆致动脉粥样硬化指数(AIP)和残余脂蛋白胆固醇(RLP-C)指数进行比较。
    本研究共纳入12,127人,2,147名参与者(17.7%)在5年的随访中发展为NAFLD。ZJU四分位数较高的参与者往往是女性,并且具有较高的肝酶(包括ALP,GGT,ALT,AST),GLU,TC,TG,LDL和更高的NAFLD风险。第二季度、第三季度和第四季度新发NAFLD的危险比(HR)和95%置信区间(CI)为3.67(2.43至5.55),9.82(6.67至14.45),和21.67(14.82至31.69),分别在完全调整后的模型3中。随着ZJU指数的增加,累积新发NAFLD逐渐增加。在ZJU指数和新发NAFLD之间观察到显著的线性关联(趋势p<0.001)。在亚组分析中,我们注意到性别的重要互动,女性的HR为3.27(2.81,3.80),男性为2.41(2.21,2.63)(P<0.01)。ZJU指数优于其他指数,曲线下面积(AUC)为0.823,其次是AIP(AUC=0.747)和RLP-C(AUC=0.668)。
    ZJU指数成为预测非肥胖者NAFLD风险的有前途的工具,表现优于其他现有参数,包括AIP和RLP-C。这可能有助于早期发现和干预这一特定人群。
    Non-alcoholic fatty liver disease (NAFLD) is increasingly observed in non-obese individuals. The ZJU (Zhejiang University) index has been established as a new and efficient tool for detecting NAFLD, but the relationship between the ZJU index and NAFLD within non-obese individuals still remains unclear.
    A post-hoc evaluation was undertaken using data from a health assessment database by the Wenzhou Medical Center. The participants were divided into four groups based on the quartile of the ZJU Index. Cox proportional hazards regression, Kaplan-Meier analysis and tests for linear trends were used to evaluate the relationship between the ZJU index and NAFLD incidence. Subgroup analysis was conducted to test the consistency of the correlation between ZJU and NAFLD in subsgroups. Receiver operative characteristic (ROC) curve analysis was performed to evaluate the predictive performance of the ZJU index, compared with the Atherogenic index of plasma (AIP) and Remnant lipoprotein cholesterol (RLP-C) index.
    A total of 12,127 were included in this study, and 2,147 participants (17.7%) developed NAFLD in 5 years follow-up. Participants in higher ZJU quartiles tended to be female and have higher liver enzymes (including ALP, GGT, ALT, AST), GLU, TC, TG, LDL and higher NAFLD risk. Hazard Ratios (HR) and 95% confidence intervals (CI) for new-onset NAFLD in Q2, Q3, and Q4 were 3.67(2.43 to 5.55), 9.82(6.67 to 14.45), and 21.67(14.82 to 31.69) respectively in the fully adjusted model 3. With increased ZJU index, the cumulative new-onset NAFLD gradually increased. Significant linear associations were observed between the ZJU index and new-onset NAFLD (p for trend all<0.001). In the subgroup analysis, we noted a significant interaction in sex, with HRs of 3.27 (2.81, 3.80) in female and 2.41 (2.21, 2.63) in male (P for interaction<0.01). The ZJU index outperformed other indices with an area under the curve (AUC) of 0.823, followed by AIP (AUC=0.747) and RLP-C (AUC=0.668).
    The ZJU index emerges as a promising tool for predicting NAFLD risk in non-obese individuals, outperforming other existing parameters including AIP and RLP-C. This could potentially aid in early detection and intervention in this specific demographic.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:自评估健康(SRH)被广泛认为是随后死亡风险的临床重要预测因子。尽管COVID-19可能会损害SRH,这种关系尚未得到广泛研究。本研究旨在检查习惯性睡眠持续时间之间的相关性,感染后睡眠时间的变化,和SRH在经历过SARS-CoV-2感染的受试者中。
    方法:来自16个国家的参与者参加了2021年国际COVID睡眠研究-II(ICOSS-II)在线调查。共有10794名参与者被纳入分析,包括1,509名COVID-19个体(他们报告说他们的COVID-19检测呈阳性)。使用0-100线性视觉模拟量表评估SRH。<6小时和>9小时的习惯性睡眠持续时间被定义为短期和长期习惯性睡眠持续时间。分别。感染≤-2h和≥1h后习惯性睡眠持续时间的变化定义为减少或增加,分别。
    结果:COVID-19参与者的SRH评分低于未感染参与者,那些患有更严重的COVID-19的人有更低的SRH评分趋势。在对经历过COVID-19的参与者的多元回归分析中,感染后习惯性睡眠时间的减少和增加与控制睡眠质量后SRH降低显着相关(β=-0.056和-0.058,两者p<0.05);然而,目前的短期或长期习惯性睡眠持续时间与SRH之间的关联可以忽略不计.多项logistic回归分析显示,习惯性睡眠时间减少与疲劳增加显著相关(比值比[OR]=1.824,p<0.01),呼吸急促(OR=1.725,p<0.05),腹泻/恶心/呕吐(OR=2.636,p<0.01),和幻觉(OR=5.091,p<0.05),而习惯性睡眠时间的增加与疲劳的增加显着相关(OR=1.900,p<0.01)。
    结论:SARS-CoV-2感染后习惯性睡眠持续时间的变化与SRH降低相关。习惯性睡眠时间减少或增加可能与COVID-19后症状有双向关系。需要进一步的研究来更好地了解这些关系的潜在机制,以改善COVID-19患者的SRH。
    Self-rated health (SRH) is widely recognized as a clinically significant predictor of subsequent mortality risk. Although COVID-19 may impair SRH, this relationship has not been extensively examined. The present study aimed to examine the correlation between habitual sleep duration, changes in sleep duration after infection, and SRH in subjects who have experienced SARS-CoV-2 infection.
    Participants from 16 countries participated in the International COVID Sleep Study-II (ICOSS-II) online survey in 2021. A total of 10,794 of these participants were included in the analysis, including 1,509 COVID-19 individuals (who reported that they had tested positive for COVID-19). SRH was evaluated using a 0-100 linear visual analog scale. Habitual sleep durations of < 6 h and > 9 h were defined as short and long habitual sleep duration, respectively. Changes in habitual sleep duration after infection of ≤ -2 h and ≥ 1 h were defined as decreased or increased, respectively.
    Participants with COVID-19 had lower SRH scores than non-infected participants, and those with more severe COVID-19 had a tendency towards even lower SRH scores. In a multivariate regression analysis of participants who had experienced COVID-19, both decreased and increased habitual sleep duration after infection were significantly associated with lower SRH after controlling for sleep quality (β = -0.056 and -0.058, respectively, both p < 0.05); however, associations between current short or long habitual sleep duration and SRH were negligible. Multinomial logistic regression analysis showed that decreased habitual sleep duration was significantly related to increased fatigue (odds ratio [OR] = 1.824, p < 0.01), shortness of breath (OR = 1.725, p < 0.05), diarrhea/nausea/vomiting (OR = 2.636, p < 0.01), and hallucinations (OR = 5.091, p < 0.05), while increased habitual sleep duration was significantly related to increased fatigue (OR = 1.900, p < 0.01).
    Changes in habitual sleep duration following SARS-CoV-2 infection were associated with lower SRH. Decreased or increased habitual sleep duration might have a bidirectional relation with post-COVID-19 symptoms. Further research is needed to better understand the mechanisms underlying these relationships for in order to improve SRH in individuals with COVID-19.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:探讨雄激素剥夺治疗(ADT)对亚裔前列腺癌患者健康相关生活质量(HRQOL)的影响。
    方法:READT(亚洲前列腺癌患者ADT效果的真实评估)是一个多中心,前瞻性观察性研究,涉及四个亚洲人群的六个地点。我们招募了符合条件的前列腺癌患者,选择单独或联合使用ADT,而在12个月内没有新辅助或辅助ADT。EuroQoL-5维度,5级量表(EQ-5D-5L)效用指数评分和视觉模拟量表(VAS)在基线时进行评估,6月和12月。
    结果:在2016年9月至2020年5月期间,共有504名患者被纳入READT,其中52.9%被诊断为转移性前列腺癌。在442/504(87.7%)的患者中可评估EQ-5D-5L。总体基线EQ-5D-5L效用指数评分为0.924(四分位距[IQR]0.876-1.000)。我们观察到不同人群之间基线EQ-5D-5L效用指数得分的统计学差异,台湾和香港的EQ-5D-5L效用指数中位数为1,中国为0.897,马来西亚为0.838。在多个处理时间点观察到类似的趋势。与I-III期前列腺癌相比,IV期前列腺癌与较低的基线EQ-5D-5L效用指数得分显着相关。产生的中值无效性值为-0.080。参与者有较高的中位数VAS(80,IQR70-90),表明ADT启动期间的整体健康状况平均良好。
    结论:该研究强调了在现实世界中接受ADT的各种亚洲前列腺癌患者在健康状态效用指数评分方面的差异。我们的发现将对成本效益评估和政策决策提供信息和有用。
    OBJECTIVE: To investigate the effect of androgen deprivation therapy (ADT) on health-related quality of life (HRQOL) in Asian men with all stages of prostate cancer.
    METHODS: READT (real-life evaluation of the effect of ADT in prostate cancer patients in Asia) was a multi-center, prospective observational study involving six sites across four Asian populations. We enrolled eligible prostate cancer patients, who opted for ADT alone or in combination without prior neoadjuvant or adjuvant ADT within 12 months. The EuroQoL-5 dimensions, 5 level scale (EQ-5D-5L) utility index scores and visual analog scale (VAS) were evaluated at baseline, month 6 and month 12.
    RESULTS: A total of 504 patients were recruited into READT between September 2016 and May 2020 with 52.9% diagnosed with metastatic prostate cancer. The EQ-5D-5L was evaluable in 442/504 (87.7%) of patients. Overall baseline EQ-5D-5L utility index score was 0.924 (interquartile range [IQR] 0.876-1.000). We observed a statistically significant difference in baseline EQ-5D-5L utility index score among different populations with a median EQ-5D-5L utility index score of 1 for Taiwan & Hong Kong, 0.897 for China and 0.838 for Malaysia. Similar trend was observed throughout multiple treatment time-points. Stage IV prostate cancer were significantly associated with a lower baseline EQ-5D-5L utility index score compared to stage I-III prostate cancer, producing a median disutility value of -0.080. Participants had a high median VAS (80, IQR 70-90), indicating good overall health on average during ADT initiation.
    CONCLUSIONS: The study highlights the differences in health state utility index scores among various Asian prostate cancer patients receiving ADT at real-world setting. Our findings will be informative and useful in cost-effectiveness evaluation and policy decision making.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    非传染性疾病(NCDs)是全球死亡和残疾的主要原因。强有力的证据表明,可改变的生活方式因素,如不健康的饮食,吸烟,饮酒和缺乏身体活动是非传染性疾病的主要原因。尽管中国已经发布了一系列非传染性疾病管理指南,这些指南主要侧重于针对临床医生的临床实践,而不是一般人群,基于可改变的生活方式因素的非传染性疾病预防证据已经混乱。因此,迫切需要为中国普通人群提供全面和循证的非传染性疾病风险管理指导。为了实现这一总体目标,我们计划制定一系列专家共识,涵盖15种主要非传染性疾病,针对中国普通人群的健康风险管理。这些共识的目的是(1)确定并推荐适合中国人群的风险评估方法;(2)通过整合当前最佳证据和专家意见,为预防主要非传染性疾病提出建议。
    对于每个专家共识,我们将成立一个由40至50名成员组成的共识工作组。共识问题将通过整合文献综述来制定,专家意见,和在线调查。系统评价将被视为主要证据来源。如果没有符合条件的系统审查,我们会进行新的系统审查,方法学质量低,或现有的系统评价已发表超过3年。我们将根据分级方法评估证据质量并提出建议。共识将根据医疗保健实践指南报告项目(右)进行报告。
    Non-communicable diseases (NCDs) represent the leading cause of mortality and disability worldwide. Robust evidence has demonstrated that modifiable lifestyle factors such as unhealthy diet, smoking, alcohol consumption and physical inactivity are the primary causes of NCDs. Although a series of guidelines for the management of NCDs have been published in China, these guidelines mainly focus on clinical practice targeting clinicians rather than the general population, and the evidence for NCD prevention based on modifiable lifestyle factors has been disorganized. Therefore, comprehensive and evidence-based guidance for the risk management of major NCDs for the general Chinese population is urgently needed. To achieve this overarching aim, we plan to develop a series of expert consensuses covering 15 major NCDs on health risk management for the general Chinese population. The objectives of these consensuses are (1) to identify and recommend suitable risk assessment methods for the Chinese population; and (2) to make recommendations for the prevention of major NCDs by integrating the current best evidence and experts\' opinions.
    For each expert consensus, we will establish a consensus working group comprising 40-50 members. Consensus questions will be formulated by integrating literature reviews, expert opinions, and an online survey. Systematic reviews will be considered as the primary evidence sources. We will conduct new systematic reviews if there are no eligible systematic reviews, the methodological quality is low, or the existing systematic reviews have been published for more than 3 years. We will evaluate the quality of evidence and make recommendations according to the GRADE approach. The consensuses will be reported according to the Reporting Items for Practice Guidelines in Healthcare (RIGHT).
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号